The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

7 Dec 2017 17:33

RNS Number : 7551Y
Pantheon International PLC
07 December 2017
 

 

 

PANTHEON INTERNATIONAL PLC

(the "Company")

 

 

Transaction in own Shares

 

The Company announces that on 7 December 2017, it purchased in the market 50,000 Ordinary shares of 67p each ("Ordinary Shares") at a price of 1,867.5 pence per share for cancellation.

 

Following this transaction, there are 54,114,447 Ordinary Shares in issue, none of which are held in treasury.

 

The Company will enter a close period for several weeks pending publication of its interim financial report for the half year ended 30 November 2017.

 

Enquiries:

 

Andrew Lebus or Vicki Bradley

Pantheon Ventures (UK) LLP

020 3356 1800

 

 

LEI: 2138001B3CE5S5PEE928

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSOKODNOBDDKBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.